
    
      Enrollment was terminated before the planned sample size was achieved because the principal
      investigator and the Sponsor decided that sufficient sera had been obtained to meet the
      secondary objective of the study.

      There were no safety concerns involved in the decision to stop enrollment. Subjects that were
      enrolled at the time completed the study as per protocol, the last subject last visit was on
      29 April 2004.
    
  